Faruqi & Faruqi, LLP Examines Investor Claims for QuidelOrtho

NEW YORK, June 05, 2024 – Notable securities law firm Faruqi & Faruqi, LLP, is conducting an investigation into possible claims on behalf of investors of QuidelOrtho Corporation QDEL, a prominent diagnostic solutions provider. The firm has issued a deadline reminder for investors to stake a lead plaintiff position by June 11, 2024.

Investigation into QuidelOrtho QDEL

QuidelOrtho develops, manufactures, and offers a broad array of diagnostic testing products. Their portfolio includes solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology. This global company, with its headquarters nestled in San Diego, California, is now under investigation regarding potential claims that may affect investor interests.

Deadline for Lead Plaintiff Role

Investors are reminded of the fast-approaching June 11, 2024 deadline to apply for the role of lead plaintiff in the case against QuidelOrtho. Faruqi & Faruqi, LLP encourages investors who have suffered losses in QDEL to come forward in light of the investigation.

About Faruqi & Faruqi, LLP

As a leading firm specializing in national securities litigation, Faruqi & Faruqi, LLP seeks to assist investors in recovering their financial losses due to alleged corporate wrongdoings and mismanagement. The firm's efforts are anchored in ensuring that the companies adhere to lawful securities practices for the protection and benefit of their investors.

investment, law, securities